-
1
-
-
0036771849
-
166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation
-
COI: 1:CAS:528:DC%2BD38XotlKjs7Y%3D
-
166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation. J Nucl Med 43:1383–1390
-
(2002)
J Nucl Med
, vol.43
, pp. 1383-1390
-
-
Rajendran, J.G.1
Eary, J.F.2
Bensinger, W.3
Durack, L.D.4
Vernon, C.5
Fritzberg, A.6
-
2
-
-
0029012120
-
Pharmacokinetics, dosimetry and toxicity of Holmium-166 DOTMP for bone marrow ablation in multiple myeloma
-
COI: 1:STN:280:DyaK2M3ls12lsQ%3D%3D
-
Bayouth JE, Macey DJ, Kasi LP (1995) Pharmacokinetics, dosimetry and toxicity of Holmium-166 DOTMP for bone marrow ablation in multiple myeloma. J Nucl Med 36:730–737
-
(1995)
J Nucl Med
, vol.36
, pp. 730-737
-
-
Bayouth, J.E.1
Macey, D.J.2
Kasi, L.P.3
-
4
-
-
0030611218
-
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy
-
COI: 1:CAS:528:DyaK2sXktlOqu78%3D
-
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy. Nucl Med Biol 24(3):231–237
-
(1997)
Nucl Med Biol
, vol.24
, Issue.3
, pp. 231-237
-
-
Hassfjell, S.P.1
Bruland, O.S.2
Hoff, P.3
-
5
-
-
0034964971
-
Synthesis, purification and biodistribution of (205)Bi-DOTMP, visualizing bone deposition patterns with autoradiography
-
COI: 1:CAS:528:DC%2BD3MXktVOhsrY%3D
-
Hassfjell S, Ingebrigtsen K, Bruland ØS (2001) Synthesis, purification and biodistribution of (205)Bi-DOTMP, visualizing bone deposition patterns with autoradiography. Nucl Med Biol 28(4):425–433
-
(2001)
Nucl Med Biol
, vol.28
, Issue.4
, pp. 425-433
-
-
Hassfjell, S.1
Ingebrigtsen, K.2
Bruland, Ø.S.3
-
6
-
-
84887871275
-
Radiolabeling, stability studies, and pharmacokinetic evaluation of Thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids
-
COI: 1:CAS:528:DC%2BC3sXhslyktrnJ
-
Vats K, Das T, Sarma HD, Banerjee S, Pillai MR (2013) Radiolabeling, stability studies, and pharmacokinetic evaluation of Thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids. Cancer Biother Radiopharm 28(10):737–745
-
(2013)
Cancer Biother Radiopharm
, vol.28
, Issue.10
, pp. 737-745
-
-
Vats, K.1
Das, T.2
Sarma, H.D.3
Banerjee, S.4
Pillai, M.R.5
-
7
-
-
62549141442
-
153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs
-
153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs. J Nucl Med Technol 37(1):45–52
-
(2009)
J Nucl Med Technol
, vol.37
, Issue.1
, pp. 45-52
-
-
Bryan, J.N.1
Bommarito, D.2
Kim, D.Y.3
Berent, L.M.4
Bryan, M.E.5
Lattimer, J.C.6
Henry, C.J.7
Engelbrecht, H.8
Ketring, A.9
Cutler, C.10
-
8
-
-
60849137233
-
99mTc-DOTMP and its preclinical evaluation as a multidentate imaging agent for skeletal metastases
-
COI: 1:CAS:528:DC%2BD1MXisVSrt78%3D
-
99mTc-DOTMP and its preclinical evaluation as a multidentate imaging agent for skeletal metastases. Cancer Biother Radiopharm 24(1):123–128
-
(2009)
Cancer Biother Radiopharm
, vol.24
, Issue.1
, pp. 123-128
-
-
Datta, A.1
Panwar, P.2
Chuttani, K.3
Mishra, A.K.4
-
10
-
-
84925535822
-
-
United States Pharmacopoeia 28, NF 23, p 1009 (2005)
-
(2005)
NF
, vol.23
, pp. 1009
-
-
-
11
-
-
84977779389
-
-
United States Pharmacopoeia 28, NF 23, p 1895 (2005)
-
(2005)
NF
, vol.23
, pp. 1895
-
-
|